Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia

Molecular Cancer Therapeutics

Volumn 4, Issue 6, 2005, Pages 865-875

  Banerjee, Abhijit G ^a,d   Bhattacharyya, Indraneel ^b,d   Vishwanatha, Jamboor K ^c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BIOLOGICAL MARKER; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2 DERIVATIVE; PROTEIN ANTIBODY; PSORIASIN; VERSICAN;

ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEEDBACK SYSTEM; GENE CLUSTER; GENE OVEREXPRESSION; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOPLAKIA; MOLECULAR DYNAMICS; MOUTH CANCER; MOUTH MUCOSA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOPSY; CARRIER PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DISEASE PROGRESSION; EPITHELIUM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MOUTH; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 21344453317     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0033     Document Type: Article

References (47)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184-94.
2. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53: 563-8.
3. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002;8:314-46.
4. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953;6:963-8.
5. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003;63:7769-76.
6. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 1990;87:1663-7.
7. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
8. Liu G, Loraine AE, Shigeta R, et al. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 2003;31:82-6.
9. Mendez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002;95:1482-94.
10. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003; 9:2627-31.
11. Bernstein EF, Fisher LW, Li K, LeBaron RG, Tan EM, Uitto J. Differential expression of the versican and decorin genes in photoaged and sun-protected skin. Comparison by immunohistochemical and northern analyses. Lab Invest 1995;72:662-9.
12. Banerjee AG, Liu J, Yuan Y, et al. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of Annexin II in prostate carcinomas from India and USA. Mol Cancer 2003;2:34.
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
14. Telford WG, King LE, Fraker PJ. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991;24:447-59.
15. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
16. Mendez E, Cheng C, Farwell DG, et al. Transcriptional expression profiles of oral squamous cell carcinomas. Cancer 2002;95:1482-94.
17. Ding C, Cantor CR. Quantitative analysis of nucleic acids-the last few years of progress. J Biochem Mol Biol 2004;37:1-10.
18. Etienne W, Meyer MH, Peppers J, Meyer RA Jr. Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques 2004;36: 618-6.
19. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK. Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-71.
20. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003;63:7769-76.
21. Alevizos I, Mahadevappa M, Zhang X, et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene 2001;20:6196-204.
22. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 2000;19: 3220-4.
23. Loercher A, Lee TL, Ricker JL, et al. Nuclear factor-κβ is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004;64:6511-23.
24. Ginos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004; 64:55-63.
25. Jeon GA, Lee JS, Patel V, et al. Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer 2004;112:249-58.
26. Emberley ED, Niu Y, Leygue E, et al. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003;63:1954-61.
27. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003; 9:2627-31.
28. Wang C, Fu M, D'Amico M, et al. Inhibition of cellular proliferation through IκB kinase-independent and peroxisome proliferator-activated receptor γ-dependent repression of cyclin D1. Mol Cell Biol 2001;21: 3057-70.
29. Nithipatikom K, Isbell MA, Lindholm PF, Kajdacsy-Balla A, Kaul S, Campell WB. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis 2002;19:593-601.
30. 2. Cancer Res 1986;46:3364-6.
31. 1 dysregulation in a human oral carcinoma tumour progression model. Cell Prolif 2002;35:183-92.
32. Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 2005;23: 254-66.
33. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK. Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-71.
34. Sheng H, Shao J, DuBois RN. K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 2001;61:2670-5.
35. Sheng GG, Shao JY, Shang HM, et al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology 1997;113:1883-91.
36. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK. Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-71.
37. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003;63:7769-76.
38. Emberley ED, Niu Y, Leygue E, et al. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003;63:1954-61.
39. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003; 9:2627-31.
40. Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res 2003;63:7769-76.
41. Itoh K, Mochizuki M, Ishii Y, et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Δ(12,14)-prostaglandin j(2). Mol Cell Biol 2004;24:36-45.
42. 2 metabolite generated during inflammatory processes. J Biol Chem 2002;277: 10459-66.
43. Cuzzocrea S, Wayman NS, Mazzon E, et al. The cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol Pharmacol 2002;61: 997-1007.
44. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002;62:5196-203.
45. Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P, Bosca L. Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-Δ(12,14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 2000; 20:1692-8.
46. 2 on helper T cell functions. Biochem Biophys Res Commun 2004;316:1009-14.
47. 2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Lett 2004;210:81-4.